HomeFileCoronary disease

Coronary disease

ESC 2025 | DUAL-ACS: Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes

The DUAL-ACS trial, a randomized multicenter study, was designed to evaluate whether a strategy of P2Y12 inhibitor...

ESC 2025 | OPTION-STEMI: Timing of Complete Revascularization During the Initial Hospitalization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), the optimal timing...

ESC 2025 | PULSE: Coronary CT Angiography vs Ischemia-Guided Follow-Up After Unprotected Left Main PCI

Courtesy of Dr. Juan Manuel Pérez. Unprotected left main (ULM) percutaneous coronary intervention (PCI) remains associated with a...

Pulsed-Field Ablation: Proximity to Coronary Vessels and the Unresolved Issue of Induced Vasospasm

Pulsed-field ablation (PFA) has emerged as a promising technique in the treatment of atrial fibrillation, thanks to...

Is It Useful to Index the Minimum Lumen Area to Ventricular Mass to Identify Functional Left Main Coronary Stenosis?

Courtesy of Dr. Juan Manuel Pérez. The assessment of intermediate left main coronary artery (LMCA) lesions remains a...

Abbreviated Dual Antiplatelet Therapy with Prasugrel: 4D-ACS

The optimal duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) remains subject to controversy....

Use of Plaque Modifying Devices in Calcified Left Main Lesions

Treating severely calcified left main coronary artery (LMCA) lesions is one of the greatest challenges in interventional...

Coronary Events Following TAVI: A Registry

Between 30 and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary artery disease (CAD)....